Market Closed -
Other stock markets
|
After market 03:47:35 pm | |||
3 EUR | +1.35% | 2.995 | -0.17% |
Mar. 27 | Heidelberg Pharma Wins US FDA Orphan Drug Designation for Multiple Myeloma Treatment | MT |
Mar. 25 | Transcript : Heidelberg Pharma AG, 2023 Earnings Call, Mar 25, 2024 |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- HPHA Stock
- Revisions Heidelberg Pharma AG